期刊文献+

沙格列汀及其差向异构体的构型研究

Study on the Configuration of Saxagliptin and It's Epimerides
暂未订购
导出
摘要 参考文献方法合成了沙格列汀及其3种差向异构体,通过红外光谱(FT-IR)和多种1D和2D NMR实验确认了它们的化学结构,包括1 H,13 C,DEPT90,DEPT135,1 H-1 HCOSY,HSQC和HMBC实验等.进行了沙格列汀及3种差向异构体的2D NOESY实验,得到其分子内NOE数据,研究这些NOE实验结果,分别证实了它们的立体构型.培养了沙格列汀的晶体,其单晶X射线衍射实验结果与核磁共振实验结果相符合,沙格列汀晶体构型、溶液构型(NMR实验结果)和沙格列汀结合受体蛋白的构型是一致的. Saxagliptin and it's three epimerides were synthesized according to the reported literatures. The chemical structures of these compounds were confirmed through FT-IR,1D and 2D NMR spectroscopies. These experiments included 1H ,13C,DEPT90 ,DEPT135,1 H-1 H COSY, HSQC and HMBC etc. Their configurations were verified using NOE results obtained NMR NOESY experiments. The crystal structure of saxagliptin from X-ray diffraction experiment matched well with the configuration from NMR experiments. The configurations of saxagliptin of crystal form,in solution and after binding to its protein acceptor were same.
作者 孙艳美 张勇 曹文婷 王秋艳 原现瑞 SUN Yanmei ZHANG Yong CAO Wenting WANG Qiuyan YUAN Xianrui(School of Chemical and Pharmaceutical Engineering,Hebei University of Science and Technology,Hebei Shijiazhuang 050018,China Analysis and Testing Center,Hebei University of Science and Technology,Hebei Shijiazhuang 050018,China)
出处 《河北师范大学学报(自然科学版)》 CAS 2017年第1期50-57,共8页 Journal of Hebei Normal University:Natural Science
基金 河北省引进留学人员资助项目(C2013003018)
关键词 沙格列汀 NOE实验 立体构型 差向异构体 saxagliptin NOE results configuration epimerides
  • 相关文献

参考文献4

二级参考文献41

  • 1胡红雨,鲁子贤.核磁共振法研究蛋白质和多肽的结构和功能[J].化学通报,1995(7):14-22. 被引量:12
  • 2王瑞瑶,高峰,金天柱.稀土-氨基酸配合物的结构化学[J].化学通报,1996(10):14-20. 被引量:43
  • 3裘祖义 裴奉奎.核磁共振谱[M].北京:科学出版社,1989.35.
  • 4李立璞.固体NMR和LC-NMR.核磁共振应用研讨会论文集[M].北京:北京理化分析测度技术学会,1997.28.
  • 5UK Prospective Diabetes Study(UKPDS)Group.Intensiveblood-glucose control with sulphonylureas or insulin comparedwith conventional treatment and risk of complications in pa-tients with type 2diabetes(UKPDS 33).Lancet,1998,352:837-853.
  • 6Boulton D,Tang A,Patel C,et al.Pharmacokinetics of thedipeptidyl peptidase-4inhibitor saxagliptin in subjects with re-nal impairment.Endo Abstr,2009,20:357.
  • 7Rosenstock J,Sankoh S,List JF.Glucose-lowering activity ofthe dipeptidyl peptidase-4inhibitor saxagliptin in drug-navepatients with type 2diabetes.Diabetes Obes Metab,2008,10:376-386.
  • 8Rosenstock J,Aguilar-Salinas C,Klein E,et al.Effect of saxa-gliptin monotherapy in treatment-naive patients with type 2di-abetes.Curr Med Res Opin,2009,25:2401-2411.
  • 9Defronzo RA,Hissa MN,Garber AJ,et al.The efficacy andsafety of saxagliptin when added to metformin therapy in pa-tients with inadequately controlled type 2diabetes with met-formin alone.Diabetes Care,2009,32:1649-1655.
  • 10Gke B,Gallwitz B,Eriksson J,et al.Saxagliptin is non-infe-rior to glipizide in patients with type 2diabetes mellitus inade-quately controlled on metformin alone:a 52-week randomisedcontrolled trial.Int J Clin Pract,2010,64:1619-1631.

共引文献87

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部